<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="article-commentary" dtd-version="3.0" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosntds</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Neglected Tropical Diseases</journal-title></journal-title-group><issn pub-type="epub">1935-2735</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07-PNTD-EC-0176R1</article-id><article-id pub-id-type="doi">10.1371/journal.pntd.0000076</article-id><article-categories><subj-group subj-group-type="heading"><subject>Expert Commentary</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Infectious Diseases/Neglected Tropical Diseases</subject></subj-group></article-categories><title-group><article-title>Ivermectin Resistance in <italic>Onchocerca volvulus:</italic> Toward
                    a Genetic Basis</article-title><alt-title alt-title-type="running-head">Ivermectin Resistance in
                    <italic>Onchocerca</italic></alt-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lustigman</surname><given-names>Sara</given-names></name><xref ref-type="aff" rid="aff1">
                        <sup>1</sup>
                    </xref><xref ref-type="corresp" rid="cor1">
                        <sup>*</sup>
                    </xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>McCarter</surname><given-names>James P.</given-names></name><xref ref-type="aff" rid="aff2">
                        <sup>2</sup>
                    </xref><xref ref-type="aff" rid="aff3">
                        <sup>3</sup>
                    </xref></contrib></contrib-group><aff id="aff1">
                <label>1</label>
                <addr-line>Laboratory of Molecular Parasitology, Lindsley F. Kimball Research
                    Institute, New York Blood Center, New York, New York, United States of
                America</addr-line>
            </aff><aff id="aff2">
                <label>2</label>
                <addr-line>Divergence Inc., St. Louis, Missouri, United States of
                America</addr-line>
            </aff><aff id="aff3">
                <label>3</label>
                <addr-line>Department of Genetics, Washington University School of Medicine, St.
                    Louis, Missouri, United States of America</addr-line>
            </aff><contrib-group><contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Yamey</surname><given-names>Gavin</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">PLoS, United States of America</aff><author-notes><corresp id="cor1">* E-mail: <email xlink:type="simple">slustigman@nybloodcenter.org</email></corresp><fn fn-type="conflict"><p>SL has received research grants for the development of anti-Onchocerca vaccines
                    and macrofilaricides. JPM is a share-holder and employee of Divergence, Inc., a
                    company that works on parasite control in plants, animals, and humans.</p></fn></author-notes><pub-date pub-type="collection"><month>10</month><year>2007</year></pub-date><pub-date pub-type="epub"><day>30</day><month>8</month><year>2007</year></pub-date><volume>1</volume><issue>1</issue><elocation-id>e76</elocation-id><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2007</copyright-year><copyright-holder>Lustigman, McCarter</copyright-holder><license><license-p>This is an open-access article distributed
                under the terms of the Creative Commons Attribution License, which permits
                unrestricted use, distribution, and reproduction in any medium, provided the
                original author and source are credited.</license-p></license></permissions><related-article page="e72" related-article-type="commentary-article" vol="1" xlink:href="info:doi/10.1371/journal.pntd.0000072" xlink:title="Research Article" xlink:type="simple">
                <article-title>Genetic Selection of Low Fertile <italic>Onchocerca volvulus</italic>
                    by Ivermectin Treatment</article-title>
            </related-article><funding-group><funding-statement>The authors received no specific funding for this study.</funding-statement></funding-group><counts><page-count count="3"/></counts></article-meta></front><body><sec id="s1"><title>Background</title><p>Onchocerciasis (river blindness) is a human disease caused by the filarial worm
                    <italic>Onchocerca volvulus.</italic> Adult worms can live for over a decade in
                skin nodules of affected humans, releasing millions of microfilariae that cause
                debilitating itching and blindness <xref ref-type="bibr" rid="pntd.0000076-Richards1">[1]</xref>. An estimated 37
                million people are infected <xref ref-type="bibr" rid="pntd.0000076-African1">[2]</xref>, and there are 46,000 new cases of blindness
                annually (<ext-link ext-link-type="uri" xlink:href="http://www.apoc.bf/" xlink:type="simple">http://www.apoc.bf/</ext-link>).</p><p>International programs supported by the World Health Organization and many other
                groups have worked to control the impact of onchocerciasis using vector control with
                insecticides beginning in 1974 and mass drug administration (MDA) with ivermectin
                (IVM, brand name Mectizan) beginning in 1987 (<xref ref-type="fig" rid="pntd-0000076-g001">Figure 1</xref>) <xref ref-type="bibr" rid="pntd.0000076-Peters1">[3]</xref>. IVM is a highly
                effective microfilaricide and inhibits female worm microfilarial production for
                several months. Annual IVM MDA reduces morbidity <xref ref-type="bibr" rid="pntd.0000076-Ejere1">[4</xref>,<xref ref-type="bibr" rid="pntd.0000076-Tielsch1">5]</xref> and lowers transmission <xref ref-type="bibr" rid="pntd.0000076-Boussinesq1">[6</xref>,<xref ref-type="bibr" rid="pntd.0000076-Collins1">7]</xref>. From 1974 to
                2002, the Onchocerciasis Control Programme (OCP) in West Africa greatly decreased
                    <italic>O. volvulus</italic> transmission in the 11 OCP countries and prevented
                600,000 cases of blindness <xref ref-type="bibr" rid="pntd.0000076-Molyneux1">[8</xref>–<xref ref-type="bibr" rid="pntd.0000076-Basez1">10]</xref>. IVM without vector control has been the principal tool for
                the Onchocerciasis Elimination Program of the Americas (1992–present)
                    <xref ref-type="bibr" rid="pntd.0000076-Boatin1">[9]</xref>
                and the African Programme for Onchocerciasis Control (1995–present). In
                the Americas, where <italic>O. volvulus</italic> is less common, the Onchocerciasis
                Elimination Program has substantially reduced transmission and is on track to
                eliminate the disease <xref ref-type="bibr" rid="pntd.0000076-Boatin1">[9]</xref>.</p><fig id="pntd-0000076-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0000076.g001</object-id><label>Figure 1</label><caption><title>Distribution of Onchocerciasis Showing Current Status of Global
                        Onchocerciasis Control.</title><p>Red shading represents areas receiving ivermectin treatment. Yellow shading
                        represents areas requiring further epidemiological surveys. Green shading
                        indicates the area covered by the OCP in West Africa. Pink zones indicate
                        the special intervention zones, i.e., previous OCP areas receiving
                        ivermectin and some vector control. Figure from <xref ref-type="bibr" rid="pntd.0000076-Basez1">[10]</xref>.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000076.g001" xlink:type="simple"/></fig><p>The African Programme for Onchocerciasis Control has extended treatment to 19
                countries beyond those originally included in the OCP through sustainable
                community-directed IVM treatment <xref ref-type="bibr" rid="pntd.0000076-Richards1">[1</xref>,<xref ref-type="bibr" rid="pntd.0000076-Remme1">11]</xref>. By the end of 2005, 400 million treatments had been supplied
                in Africa by Merck’s Mectizan Donation Program, with an estimated 40
                million people treated by nearly 300,000 community distributors (<ext-link ext-link-type="uri" xlink:href="http://www.apoc.bf/" xlink:type="simple">http://www.apoc.bf/</ext-link>). Nevertheless, the ecology of the disease in
                Africa, including the broad geographic range of <italic>O. volvulus</italic> and its
                blackfly vector, leads to the estimation that IVM treatment of at least
                65% of the population for 25 or more years will be necessary to eliminate
                infection <xref ref-type="bibr" rid="pntd.0000076-Boatin1">[9</xref>,<xref ref-type="bibr" rid="pntd.0000076-Winnen1">12]</xref>. There are
                significant logistical obstacles to achieving such broad-ranging and prolonged
                treatment, and there is also concern that <italic>O. volvulus</italic> resistance to
                IVM will emerge. IVM resistance has become widespread in many parasitic nematodes of
                livestock <xref ref-type="bibr" rid="pntd.0000076-Coles1">[13</xref>,<xref ref-type="bibr" rid="pntd.0000076-Coles2">14]</xref>. At present there
                are no alternative drugs for IVM for use in the <italic>Onchocerca</italic> MDA
                programs that reduce microfilariae or kill adult worms, which can live up to 15
                years in the human host.</p><p>The emergence of drug-resistant <italic>O. volvulus</italic> has been suggested by
                reports of patients failing to respond to IVM treatment <xref ref-type="bibr" rid="pntd.0000076-Awadzi1">[15</xref>,<xref ref-type="bibr" rid="pntd.0000076-Awadzi2">16]</xref>. A recent report from Ghana has
                provided the first proof of IVM resistance in <italic>O. volvulus:</italic> Mike
                Osei-Atweneboana and colleagues showed that the ability of IVM to suppress skin
                microfilariae repopulation was reduced in some communities that had received
                6–18 years of IVM MDA <xref ref-type="bibr" rid="pntd.0000076-OseiAtweneboana1">[17]</xref>. The authors
                predict that a high rate of repopulation of skin with microfilariae will allow
                continued parasite transmission, possibly with IVM-resistant <italic>O.
                volvulus</italic> leading to disease recrudescence. Additionally, studies have
                associated IVM resistance with genetic markers <xref ref-type="bibr" rid="pntd.0000076-Kohler1">[18</xref>–<xref ref-type="bibr" rid="pntd.0000076-Ardelli4">25]</xref>, particularly the
                    β<italic>-tubulin</italic> gene in human <italic>O. volvulus</italic>
                and the livestock nematode parasite <italic>Haemonchus contortus</italic>
                <xref ref-type="bibr" rid="pntd.0000076-Eng1">[22</xref>,<xref ref-type="bibr" rid="pntd.0000076-Eng2">26]</xref>. However, previous
                    <italic>O. volvulus</italic> genotyping studies were non-longitudinal, using
                worms collected from different IVM-naïve and treated individuals.</p></sec><sec id="s2"><title>A New Study: IVM Causes Genetic Selection on <italic>O. volvulus</italic></title><p>A new study by Catherine Bourguinat and colleagues published in <italic>PLoS
                    Neglected Tropical Diseases</italic> extends these previous reports and
                concludes not only that IVM causes genetic selection on <italic>O. volvulus</italic>
                worms, but that this selection is also associated with a lower reproductive rate of
                the female parasites <xref ref-type="bibr" rid="pntd.0000076-Bourguinat2">[27]</xref>. In this study of <italic>O. volvulus</italic>
                treatment in a hyperendemic region of central Cameroon, parasite genotypes
                    (β-<italic>tubulin</italic> gene and two controls) and phenotypes
                (female fertility) were characterized in worms collected from the same individuals
                before and after four or 13 IVM treatments over three years. Parasites were
                collected pre- and post-treatment from clinical trial patients in four IVM treatment
                groups: 150 µg/kg of body weight annually or three-monthly, and 800
                µg/kg annually or three-monthly.</p><p>Analyses of the genetic polymorphism in parasites pre- and post- treatment clearly
                showed a significant selection for β-<italic>tubulin</italic> heterozygotes
                in female worms. The most marked effect was in the three-monthly treated groups,
                where the frequency of the β-<italic>tubulin</italic>
                “aa” homozygotes post-IVM was reduced on average from
                68.6% to 25.6%, while the “ab”
                heterozygotes increased from 20.9% to 69.2% over three years.
                Moreover, β-<italic>tubulin</italic> “aa” homozygous
                females were significantly more fertile than heterozygotes before treatment
                (67% versus 37%) and 12 months after the last IVM dose in the
                groups treated annually (60% versus 17%). No significant
                selection was observed in the control genes.</p></sec><sec id="s3"><title>Strengths and Limitations of the Study</title><p>A major strength of this study is that the <italic>O. volvulus</italic> parasites
                were collected from the same individuals before and after IVM treatments. Therefore
                the observed changes in genotype frequencies between IVM-naïve and treated
                    <italic>O. volvulus</italic> populations are not due to factors such as
                geographical or sampling effects.</p><p>The main limitation of this study was that some worm samples could not be genotyped,
                thus reducing the number that could be analyzed, particularly after treatment. This
                limitation might also have impeded the genotyping of DNA, ideally prepared from worm
                sections instead of just whole females. What is given as a single genotype is, in
                fact, a consensus of multiple genotypes including the adult female body and progeny
                (uterine embryos and microfilariae). Furthermore, the samples from unfertile
                females, which probably represent true singletons, were treated the same as those
                from females classified as being of low or high fertility. Consequently, the study
                leaves unanswered questions including whether the selection of the
                    β-<italic>tubulin</italic> heterozygote genotypes is on the females or
                their progeny. If it is on the progeny, questions remain regarding the fitness and
                susceptibility to IVM treatment of the β-<italic>tubulin</italic>
                heterozygote microfilariae once they develop into the infective stage larvae and
                enter a new human host.</p><p>The authors do not present a hypothesis to explain why IVM causes selection for
                    β-<italic>tubulin</italic> heterozygote genotypes. The glutamate-gated
                chloride channels are thought to be involved in the mode of action of IVM and
                resistance to the drug <xref ref-type="bibr" rid="pntd.0000076-Njue1">[28]</xref>. Treatment with IVM is known to cause a loss of
                polymorphism not only at certain β-<italic>tubulin</italic> gene loci, but
                also at certain loci of the genes encoding the gamma-aminobutyric acid receptor,
                glutamate-gated chloride channel, and ATP-binding cassette transporter of
                IVM-resistant <italic>H. contortus</italic>
                <xref ref-type="bibr" rid="pntd.0000076-Ardelli2">[23]</xref>. It
                will therefore be important to examine for polymorphisms in these genes in the
                uniquely collected <italic>O. volvulus</italic> female worms described in this study
                and in future studies.</p><p>Despite these caveats, the study indicates that IVM causes genetic selection on
                    <italic>O. volvulus</italic> worms and points to the daunting possibility of the
                spread of IVM-resistant parasites in endemic regions that have been treated with
                IVM.</p></sec><sec id="s4"><title>Implications of the Study for River Blindness Control</title><p>The finding that IVM treatment selected for β-<italic>tubulin</italic>
                heterozygotes and that this selection was dependent on dosage raises important
                concerns for the current river blindness control programs. These concerns are
                heightened by the fact that this gene has been linked with IVM resistance in another
                parasitic nematode <xref ref-type="bibr" rid="pntd.0000076-Eng2">[26]</xref>, and by the recent evidence that IVM resistance
                is occurring in <italic>O. volvulus</italic>
                <xref ref-type="bibr" rid="pntd.0000076-OseiAtweneboana1">[17]</xref>. Semiannual or more frequent treatments are ongoing
                in some endemic areas and are under consideration in other areas. Such treatment
                might increase the selection pressure. Therefore, Bourguinat and
                colleagues’ study is a wake-up call for control programs to select their
                treatment regimens carefully and to develop plans for detecting IVM resistance and
                the associated genetic markers (control programs will require additional funding for
                these plans). This study presents a possible structure of study design that will
                incorporate the detection and validation of the genetic markers associated with IVM
                resistance.</p><p>Simultaneously, we need to greatly increase our current level of effort and support
                to develop and test a new generation of control tools for onchocerciasis. These
                tools should include both vaccines and macrofilaricides (drugs which kill adult
                worms) that have new classes of chemistry with novel modes of action. Recent
                breakthroughs now make macrofilaricide development more feasible, and accordingly
                such development is now a high-priority goal with the World Health
                Organization’s Special Programme for Research and Training in Tropical
                Diseases and the Bill and Melinda Gates Foundation <xref ref-type="bibr" rid="pntd.0000076-Behm1">[29</xref>,<xref ref-type="bibr" rid="pntd.0000076-Nwaka1">30]</xref>. The development of an
                    anti-<italic>Onchocerca</italic> vaccine has been the focus of research
                supported by the Edna McConnell Clark Foundation <xref ref-type="bibr" rid="pntd.0000076-Cook1">[31]</xref>. It may be possible to
                link such a vaccine with drug treatments in a program of vaccine-linked chemotherapy
                    <xref ref-type="bibr" rid="pntd.0000076-Hotez1">[32</xref>,<xref ref-type="bibr" rid="pntd.0000076-Hotez2">33]</xref>. These new
                generations of control tools would complement the present control
                measure—the establishment of sustainable community-directed treatment with
                IVM—and ultimately support the long-term goal of eliminating
                onchocerciasis as a public health problem in Sub-Saharan Africa.</p></sec></body><back><ref-list><title>References</title><ref id="pntd.0000076-Richards1"><label>1</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Richards</surname><given-names>FO</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Boatin</surname><given-names>B</given-names></name><name name-style="western"><surname>Sauerbrey</surname><given-names>M</given-names></name><name name-style="western"><surname>Seketeli</surname><given-names>A</given-names></name></person-group>
                    <year>2001</year>
                    <article-title>Control of onchocerciasis today: status and challenges.</article-title>
                    <source>Trends Parasitol</source>
                    <volume>17</volume>
                    <fpage>558</fpage>
                    <lpage>563</lpage>
                </element-citation></ref><ref id="pntd.0000076-African1"><label>2</label><element-citation publication-type="journal" xlink:type="simple">
                    <collab xlink:type="simple">African Programme for Onchocerciasis Control</collab>
                    <year>2005</year>
                    <article-title>Final communiqué of the 11th session of the Joint
                        Action Forum (JAF) of APOC, Paris, France, 6–9 December 2005.</article-title>
                    <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.apoc.bf/en/download.htm" xlink:type="simple">http://www.apoc.bf/en/download.htm</ext-link>. Accessed 3 August
                    2007</comment>
                </element-citation></ref><ref id="pntd.0000076-Peters1"><label>3</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>DH</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>T</given-names></name></person-group>
                    <year>2004</year>
                    <article-title>Mectizan Donation Program: Evaluation of a
                        public–private partnership.</article-title>
                    <source>Trop Med Int Health</source>
                    <volume>9</volume>
                    <fpage>A4</fpage>
                    <lpage>A15</lpage>
                </element-citation></ref><ref id="pntd.0000076-Ejere1"><label>4</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ejere</surname><given-names>H</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>E</given-names></name><name name-style="western"><surname>Wormald</surname><given-names>R</given-names></name></person-group>
                    <year>2001</year>
                    <article-title>Ivermectin for onchocercal eye disease (river blindness).</article-title>
                    <source>Cochrane Database Syst Rev</source>
                    <fpage>CD002219</fpage>
                </element-citation></ref><ref id="pntd.0000076-Tielsch1"><label>5</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Tielsch</surname><given-names>JM</given-names></name><name name-style="western"><surname>Beeche</surname><given-names>A</given-names></name></person-group>
                    <year>2004</year>
                    <article-title>Impact of ivermectin on illness and disability associated with
                        onchocerciasis.</article-title>
                    <source>Trop Med Int Health</source>
                    <volume>9</volume>
                    <fpage>A45</fpage>
                    <lpage>A56</lpage>
                </element-citation></ref><ref id="pntd.0000076-Boussinesq1"><label>6</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Boussinesq</surname><given-names>M</given-names></name><name name-style="western"><surname>Prod'hon</surname><given-names>J</given-names></name><name name-style="western"><surname>Chippaux</surname><given-names>JP</given-names></name></person-group>
                    <year>1997</year>
                    <article-title><italic>Onchocerca volvulus:</italic> Striking decrease in
                        transmission in the Vina valley (Cameroon) after eight annual large scale
                        ivermectin treatments.</article-title>
                    <source>Trans R Soc Trop Med Hyg</source>
                    <volume>91</volume>
                    <fpage>82</fpage>
                    <lpage>86</lpage>
                </element-citation></ref><ref id="pntd.0000076-Collins1"><label>7</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Collins</surname><given-names>RC</given-names></name><name name-style="western"><surname>Gonzales-Peralta</surname><given-names>C</given-names></name><name name-style="western"><surname>Castro</surname><given-names>J</given-names></name><name name-style="western"><surname>Zea-Flores</surname><given-names>G</given-names></name><name name-style="western"><surname>Cupp</surname><given-names>MS</given-names></name><etal/></person-group>
                    <year>1992</year>
                    <article-title>Ivermectin: Reduction in prevalence and infection intensity of
                            <italic>Onchocerca volvulus</italic> following biannual treatments in
                        five Guatemalan communities.</article-title>
                    <source>Am J Trop Med Hyg</source>
                    <volume>47</volume>
                    <fpage>156</fpage>
                    <lpage>169</lpage>
                </element-citation></ref><ref id="pntd.0000076-Molyneux1"><label>8</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Molyneux</surname><given-names>DH</given-names></name></person-group>
                    <year>1995</year>
                    <article-title>Onchocerciasis control in West Africa: Current status and future
                        of the Onchocerciasis Control Programme.</article-title>
                    <source>Parasitol Today</source>
                    <volume>11</volume>
                    <fpage>399</fpage>
                    <lpage>402</lpage>
                </element-citation></ref><ref id="pntd.0000076-Boatin1"><label>9</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Boatin</surname><given-names>BA</given-names></name><name name-style="western"><surname>Richards</surname><given-names>FO</given-names><suffix>Jr</suffix></name></person-group>
                    <year>2006</year>
                    <article-title>Control of onchocerciasis.</article-title>
                    <source>Adv Parasitol</source>
                    <volume>61</volume>
                    <fpage>349</fpage>
                    <lpage>394</lpage>
                </element-citation></ref><ref id="pntd.0000076-Basez1"><label>10</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Basáñez</surname><given-names>MG</given-names></name><name name-style="western"><surname>Pion</surname><given-names>SD</given-names></name><name name-style="western"><surname>Churcher</surname><given-names>TS</given-names></name><name name-style="western"><surname>Breitling</surname><given-names>LP</given-names></name><name name-style="western"><surname>Little</surname><given-names>MP</given-names></name><etal/></person-group>
                    <year>2006</year>
                    <article-title>River blindness: A success story under threat?</article-title>
                    <source>PLoS Med</source>
                    <volume>3</volume>
                    <fpage>e371. doi:10.1371/journal.pmed.0030371</fpage>
                </element-citation></ref><ref id="pntd.0000076-Remme1"><label>11</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Remme</surname><given-names>JHF</given-names></name></person-group>
                    <year>1995</year>
                    <article-title>The African Programme for Onchocerciasis Control: Preparing to
                        launch.</article-title>
                    <source>Parasitol Today</source>
                    <volume>11</volume>
                    <fpage>403</fpage>
                    <lpage>406</lpage>
                </element-citation></ref><ref id="pntd.0000076-Winnen1"><label>12</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Winnen</surname><given-names>M</given-names></name><name name-style="western"><surname>Plaisier</surname><given-names>AP</given-names></name><name name-style="western"><surname>Alley</surname><given-names>ES</given-names></name><name name-style="western"><surname>Nagelkerke</surname><given-names>NJ</given-names></name><name name-style="western"><surname>van Oortmarssen</surname><given-names>G</given-names></name><etal/></person-group>
                    <year>2002</year>
                    <article-title>Can ivermectin mass treatments eliminate onchocerciasis in
                        Africa?</article-title>
                    <source>Bull World Health Organ</source>
                    <volume>80</volume>
                    <fpage>384</fpage>
                    <lpage>391</lpage>
                </element-citation></ref><ref id="pntd.0000076-Coles1"><label>13</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Coles</surname><given-names>GC</given-names></name></person-group>
                    <year>2006</year>
                    <article-title>Drug resistance and drug tolerance in parasites.</article-title>
                    <source>Trends Parasitol</source>
                    <volume>22</volume>
                    <fpage>348; author reply 349</fpage>
                </element-citation></ref><ref id="pntd.0000076-Coles2"><label>14</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Coles</surname><given-names>GC</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>F</given-names></name><name name-style="western"><surname>Pomroy</surname><given-names>WE</given-names></name><name name-style="western"><surname>Prichard</surname><given-names>RK</given-names></name><name name-style="western"><surname>von Samson-Himmelstjerna</surname><given-names>G</given-names></name><etal/></person-group>
                    <year>2006</year>
                    <article-title>The detection of anthelmintic resistance in nematodes of
                        veterinary importance.</article-title>
                    <source>Vet Parasitol</source>
                    <volume>136</volume>
                    <fpage>167</fpage>
                    <lpage>185</lpage>
                </element-citation></ref><ref id="pntd.0000076-Awadzi1"><label>15</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Awadzi</surname><given-names>K</given-names></name><name name-style="western"><surname>Attah</surname><given-names>SK</given-names></name><name name-style="western"><surname>Addy</surname><given-names>ET</given-names></name><name name-style="western"><surname>Opoku</surname><given-names>NO</given-names></name><name name-style="western"><surname>Quartey</surname><given-names>BT</given-names></name><etal/></person-group>
                    <year>2004</year>
                    <article-title>Thirty-month follow-up of sub-optimal responders to multiple
                        treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.</article-title>
                    <source>Ann Trop Med Parasitol</source>
                    <volume>98</volume>
                    <fpage>359</fpage>
                    <lpage>370</lpage>
                </element-citation></ref><ref id="pntd.0000076-Awadzi2"><label>16</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Awadzi</surname><given-names>K</given-names></name><name name-style="western"><surname>Boakye</surname><given-names>DA</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>G</given-names></name><name name-style="western"><surname>Opoku</surname><given-names>NO</given-names></name><name name-style="western"><surname>Attah</surname><given-names>SK</given-names></name><etal/></person-group>
                    <year>2004</year>
                    <article-title>An investigation of persistent microfilaridermias despite
                        multiple treatments with ivermectin, in two onchocerciasis-endemic foci in
                        Ghana.</article-title>
                    <source>Ann Trop Med Parasitol</source>
                    <volume>98</volume>
                    <fpage>231</fpage>
                    <lpage>249</lpage>
                </element-citation></ref><ref id="pntd.0000076-OseiAtweneboana1"><label>17</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Osei-Atweneboana</surname><given-names>MY</given-names></name><name name-style="western"><surname>Eng</surname><given-names>JK</given-names></name><name name-style="western"><surname>Boakye</surname><given-names>DA</given-names></name><name name-style="western"><surname>Gyapong</surname><given-names>JO</given-names></name><name name-style="western"><surname>Prichard</surname><given-names>RK</given-names></name></person-group>
                    <year>2007</year>
                    <article-title>Prevalence and intensity of <italic>Onchocerca volvulus</italic>
                        infection and efficacy of ivermectin in endemic communities in Ghana: A
                        two-phase epidemiological study.</article-title>
                    <source>Lancet</source>
                    <volume>369</volume>
                    <fpage>2021</fpage>
                    <lpage>2029</lpage>
                </element-citation></ref><ref id="pntd.0000076-Kohler1"><label>18</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Kohler</surname><given-names>P</given-names></name></person-group>
                    <year>2001</year>
                    <article-title>The biochemical basis of anthelmintic action and resistance.</article-title>
                    <source>Int J Parasitol</source>
                    <volume>31</volume>
                    <fpage>336</fpage>
                    <lpage>345</lpage>
                </element-citation></ref><ref id="pntd.0000076-Huang1"><label>19</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Prichard</surname><given-names>RK</given-names></name></person-group>
                    <year>1999</year>
                    <article-title>Identification and stage-specific expression of two putative
                        P-glycoprotein coding genes in <italic>Onchocerca volvulus.</italic></article-title>
                    <source>Mol Biochem Parasitol</source>
                    <volume>102</volume>
                    <fpage>273</fpage>
                    <lpage>281</lpage>
                </element-citation></ref><ref id="pntd.0000076-Ardelli1"><label>20</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ardelli</surname><given-names>BF</given-names></name><name name-style="western"><surname>Guerriero</surname><given-names>SB</given-names></name><name name-style="western"><surname>Prichard</surname><given-names>RK</given-names></name></person-group>
                    <year>2005</year>
                    <article-title>Genomic organization and effects of ivermectin selection on
                            <italic>Onchocerca volvulus</italic> P-glycoprotein.</article-title>
                    <source>Mol Biochem Parasitol</source>
                    <volume>143</volume>
                    <fpage>58</fpage>
                    <lpage>66</lpage>
                </element-citation></ref><ref id="pntd.0000076-Bourguinat1"><label>21</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Bourguinat</surname><given-names>C</given-names></name><name name-style="western"><surname>Pion</surname><given-names>SD</given-names></name><name name-style="western"><surname>Kamgno</surname><given-names>J</given-names></name><name name-style="western"><surname>Gardon</surname><given-names>J</given-names></name><name name-style="western"><surname>Gardon-Wendel</surname><given-names>N</given-names></name><etal/></person-group>
                    <year>2006</year>
                    <article-title>Genetic polymorphism of the beta-tubulin gene of
                            <italic>Onchocerca volvulus</italic> in ivermectin naive patients from
                        Cameroon, and its relationship with fertility of the worms.</article-title>
                    <source>Parasitology</source>
                    <volume>132</volume>
                    <fpage>1</fpage>
                    <lpage>8</lpage>
                </element-citation></ref><ref id="pntd.0000076-Eng1"><label>22</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Eng</surname><given-names>JK</given-names></name><name name-style="western"><surname>Prichard</surname><given-names>RK</given-names></name></person-group>
                    <year>2005</year>
                    <article-title>A comparison of genetic polymorphism in populations of
                            <italic>Onchocerca volvulus</italic> from untreated- and
                        ivermectin-treated patients.</article-title>
                    <source>Mol Biochem Parasitol</source>
                    <volume>142</volume>
                    <fpage>193</fpage>
                    <lpage>202</lpage>
                </element-citation></ref><ref id="pntd.0000076-Ardelli2"><label>23</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ardelli</surname><given-names>BF</given-names></name><name name-style="western"><surname>Prichard</surname><given-names>RK</given-names></name></person-group>
                    <year>2004</year>
                    <article-title>Identification of variant ABC-transporter genes among
                            <italic>Onchocerca volvulus</italic> collected from ivermectin-treated
                        and untreated patients in Ghana, West Africa.</article-title>
                    <source>Ann Trop Med Parasitol</source>
                    <volume>98</volume>
                    <fpage>371</fpage>
                    <lpage>384</lpage>
                </element-citation></ref><ref id="pntd.0000076-Ardelli3"><label>24</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ardelli</surname><given-names>BF</given-names></name><name name-style="western"><surname>Guerriero</surname><given-names>SB</given-names></name><name name-style="western"><surname>Prichard</surname><given-names>RK</given-names></name></person-group>
                    <year>2006</year>
                    <article-title>Ivermectin imposes selection pressure on P-glycoprotein from
                            <italic>Onchocerca volvulus:</italic> Linkage disequilibrium and
                        genotype diversity.</article-title>
                    <source>Parasitology</source>
                    <volume>132</volume>
                    <fpage>375</fpage>
                    <lpage>386</lpage>
                </element-citation></ref><ref id="pntd.0000076-Ardelli4"><label>25</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Ardelli</surname><given-names>BF</given-names></name><name name-style="western"><surname>Guerriero</surname><given-names>SB</given-names></name><name name-style="western"><surname>Prichard</surname><given-names>RK</given-names></name></person-group>
                    <year>2006</year>
                    <article-title>Characterization of a half-size ATP-binding cassette transporter
                        gene which may be a useful marker for ivermectin selection in
                            <italic>Onchocerca volvulus.</italic></article-title>
                    <source>Mol Biochem Parasitol</source>
                    <volume>145</volume>
                    <fpage>94</fpage>
                    <lpage>100</lpage>
                </element-citation></ref><ref id="pntd.0000076-Eng2"><label>26</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Eng</surname><given-names>JK</given-names></name><name name-style="western"><surname>Blackhall</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Osei-Atweneboana</surname><given-names>MY</given-names></name><name name-style="western"><surname>Bourguinat</surname><given-names>C</given-names></name><name name-style="western"><surname>Galazzo</surname><given-names>D</given-names></name><etal/></person-group>
                    <year>2006</year>
                    <article-title>Ivermectin selection on beta-tubulin: Evidence in
                            <italic>Onchocerca volvulus</italic> and <italic>Haemonchus
                        contortus.</italic></article-title>
                    <source>Mol Biochem Parasitol</source>
                    <volume>150</volume>
                    <fpage>229</fpage>
                    <lpage>235</lpage>
                </element-citation></ref><ref id="pntd.0000076-Bourguinat2"><label>27</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Bourguinat</surname><given-names>C</given-names></name><name name-style="western"><surname>Pion</surname><given-names>SDS</given-names></name><name name-style="western"><surname>Kamgno</surname><given-names>J</given-names></name><name name-style="western"><surname>Gardon</surname><given-names>J</given-names></name><name name-style="western"><surname>Duke</surname><given-names>BOL</given-names></name><etal/></person-group>
                    <year>2007</year>
                    <source>Genetic selection of low fertile <italic>Onchocerca volvulus</italic> by
                        ivermectin treatment</source>
                    <comment>PLoS Negl Trop Dis 1: e72. doi:10.1371/journal.pntd.0000072</comment>
                </element-citation></ref><ref id="pntd.0000076-Njue1"><label>28</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Njue</surname><given-names>AI</given-names></name><name name-style="western"><surname>Prichard</surname><given-names>RK</given-names></name></person-group>
                    <year>2004</year>
                    <article-title>Genetic variability of glutamate-gated chloride channel genes in
                        ivermectin-susceptible and -resistant strains of <italic>Cooperia
                        oncophora.</italic></article-title>
                    <source>Parasitology</source>
                    <volume>129</volume>
                    <fpage>741</fpage>
                    <lpage>751</lpage>
                </element-citation></ref><ref id="pntd.0000076-Behm1"><label>29</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Behm</surname><given-names>CA</given-names></name><name name-style="western"><surname>Bendig</surname><given-names>MM</given-names></name><name name-style="western"><surname>McCarter</surname><given-names>JP</given-names></name><name name-style="western"><surname>Sluder</surname><given-names>AE</given-names></name></person-group>
                    <year>2005</year>
                    <article-title>RNAi-based discovery and validation of new drug targets in
                        filarial nematodes.</article-title>
                    <source>Trends Parasitol</source>
                    <volume>21</volume>
                    <fpage>97</fpage>
                    <lpage>100</lpage>
                </element-citation></ref><ref id="pntd.0000076-Nwaka1"><label>30</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Nwaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Hudson</surname><given-names>A</given-names></name></person-group>
                    <year>2006</year>
                    <article-title>Innovative lead discovery strategies for tropical diseases.</article-title>
                    <source>Nat Rev Drug Discov</source>
                    <volume>5</volume>
                    <fpage>941</fpage>
                    <lpage>955</lpage>
                </element-citation></ref><ref id="pntd.0000076-Cook1"><label>31</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Cook</surname><given-names>JA</given-names></name><name name-style="western"><surname>Steel</surname><given-names>C</given-names></name><name name-style="western"><surname>Ottesen</surname><given-names>EA</given-names></name></person-group>
                    <year>2001</year>
                    <article-title>Towards a vaccine for onchocerciasis.</article-title>
                    <source>Trends Parasitol</source>
                    <volume>17</volume>
                    <fpage>555</fpage>
                    <lpage>558</lpage>
                </element-citation></ref><ref id="pntd.0000076-Hotez1"><label>32</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Hotez</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Ferris</surname><given-names>MT</given-names></name></person-group>
                    <year>2006</year>
                    <article-title>The antipoverty vaccines.</article-title>
                    <source>Vaccine</source>
                    <volume>24</volume>
                    <fpage>5787</fpage>
                    <lpage>5799</lpage>
                </element-citation></ref><ref id="pntd.0000076-Hotez2"><label>33</label><element-citation publication-type="journal" xlink:type="simple">
                    <person-group person-group-type="author"><name name-style="western"><surname>Hotez</surname><given-names>PJ</given-names></name></person-group>
                    <year>2007</year>
                    <article-title>Control of onchocerciasis—The next generation.</article-title>
                    <source>Lancet</source>
                    <volume>369</volume>
                    <fpage>1979</fpage>
                    <lpage>1980</lpage>
                </element-citation></ref></ref-list></back></article>